![Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease - Leaker - 2015 - British Journal of Clinical Pharmacology - Wiley Online Library Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease - Leaker - 2015 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/2997e66e-d175-4a26-b961-da3c9d4f7b17/bcp12517-fig-0001-m.jpg)
Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease - Leaker - 2015 - British Journal of Clinical Pharmacology - Wiley Online Library
Nebulized glycopyrrolate shows real-world decrease in exacerbations and hospitalizations in patients with COPD
![PDF) Dose selection for glycopyrrolate/eFlow® phase III clinical studies: Results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies PDF) Dose selection for glycopyrrolate/eFlow® phase III clinical studies: Results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies](https://i1.rgstatic.net/publication/321509214_Dose_selection_for_glycopyrrolateeFlowR_phase_III_clinical_studies_Results_from_GOLDEN_Glycopyrrolate_for_Obstructive_Lung_Disease_via_Electronic_Nebulizer_phase_II_dose-finding_studies/links/5a2628024585155dd4216ffc/largepreview.png)
PDF) Dose selection for glycopyrrolate/eFlow® phase III clinical studies: Results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies
![Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease | Cleveland Clinic Journal of Medicine Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease | Cleveland Clinic Journal of Medicine](https://www.ccjm.org/content/ccjom/85/2_suppl_1/S19/F1.large.jpg)
Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease | Cleveland Clinic Journal of Medicine
![Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram](https://www.researchgate.net/publication/347420613/figure/tbl1/AS:986275486109704@1612157808803/Long-Acting-Muscarinic-Receptor-Antagonists-LAMA-in-Clinical-Development.png)